World-Changing Malaria Vaccine
Abstract
Malaria is a life-threatening disease caused female Anopheles mosquitoesm, transmitted to people through the bites of infecton. It is preventable and curable. According to WAR-2021 (World Malaria Report), half the world's population lives at risk of malaria transmission in 87 countries and territories. The WHO African Region carries a is proportionately high share of the global malaria burden. Children under 5 accounted for about 80% of all malaria deaths in the Region. More than 260,000 African children under age 5 die from the disease annually. This review highlights the recent research in the development of the malaria vaccine.
References
2. Bruce-Chwatt, L. J. (1962). Classification of antimalarial drugs in relation to different stages in the life-cycle of the parasite: commentary on a diagram. Bulletin of the World Health Organization, 27(2), 287.
3. Duffy, P. E., & Patrick Gorres, J. (2020). Malaria vaccines since 2000: progress, priorities, products. npj Vaccines, 5(1), 1-9.
4. Sinnis, P., & Fidock, D. A. (2022). The RTS, S vaccine—a chance to regain the upper hand against malaria?. Cell, 185(5), 750-754.
5. Goodman, A. L., & Draper, S. J. (2010). Blood-stage malaria vaccines—recent progress and future challenges. Annals of Tropical Medicine & Parasitology, 104(3), 189-211.
6. Matuschewski, K. (2006). Vaccine development against malaria. Current opinion in immunology, 18(4), 449-457.
7. Hoffman, S. L., Vekemans, J., Richie, T. L., & Duffy, P. E. (2015). The march toward malaria vaccines. Vaccine, 33, D13-D23.
8. Graves, P. M., & Gelband, H. (2006). Vaccines for preventing malaria (SPf66). Cochrane Database of Systematic Reviews, (2).
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.